Matches in Wikidata for { <http://www.wikidata.org/entity/Q80381830> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q80381830 description "article scientifique publié en 2007" @default.
- Q80381830 description "artículu científicu espublizáu en xunu de 2007" @default.
- Q80381830 description "im Juni 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80381830 description "scientific article published on 01 June 2007" @default.
- Q80381830 description "wetenschappelijk artikel" @default.
- Q80381830 description "наукова стаття, опублікована в червні 2007" @default.
- Q80381830 name "Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis" @default.
- Q80381830 name "Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis" @default.
- Q80381830 type Item @default.
- Q80381830 label "Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis" @default.
- Q80381830 label "Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis" @default.
- Q80381830 prefLabel "Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis" @default.
- Q80381830 prefLabel "Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis" @default.
- Q80381830 P1433 Q80381830-E0AFE5E1-1B42-4A57-9C76-5672A93D2371 @default.
- Q80381830 P1476 Q80381830-524B9D1C-E68E-4A48-88FA-234399FA1A42 @default.
- Q80381830 P2093 Q80381830-2BF6ECBC-EA51-4442-B46D-4A2DA551176E @default.
- Q80381830 P2093 Q80381830-394E783B-507E-4EA7-A484-ECE23002C0D4 @default.
- Q80381830 P2093 Q80381830-5DBF0658-10C7-4EB8-96FD-910491CD26C8 @default.
- Q80381830 P2093 Q80381830-66232254-E062-4D28-8FB6-BBDF6390FD53 @default.
- Q80381830 P2093 Q80381830-9852E074-5DAA-4EEC-B67F-5113D3DC1335 @default.
- Q80381830 P2093 Q80381830-A64D5409-04AA-4A40-8242-C1F130759714 @default.
- Q80381830 P2093 Q80381830-CF15619D-8FA1-429F-BA3A-467BEDC3C530 @default.
- Q80381830 P2093 Q80381830-E84E1115-CB4A-4D33-8499-95A5B11531AB @default.
- Q80381830 P304 Q80381830-F7E6A4FB-854F-4001-B8DD-B63E343819C7 @default.
- Q80381830 P31 Q80381830-F039D312-0D74-4CD9-B5F7-A72518E8C9EA @default.
- Q80381830 P356 Q80381830-1E21CFBD-A50D-4385-93B0-5345409BFFB9 @default.
- Q80381830 P433 Q80381830-0EAB00C5-E2C6-4BC4-98DC-AD746B011DFA @default.
- Q80381830 P478 Q80381830-145B5D25-C0C0-4D82-8DC1-FA39CF9BB95D @default.
- Q80381830 P577 Q80381830-CF0E072D-B64A-4632-8E45-6FDB8874FA4E @default.
- Q80381830 P698 Q80381830-89C91626-1A78-4F1C-90B4-F994DDC236DF @default.
- Q80381830 P921 Q80381830-7FAFE360-36A2-4EB7-BD81-C0925F5BE0C1 @default.
- Q80381830 P921 Q80381830-B90A80B3-1F29-4D70-88FF-A7AF768D97EB @default.
- Q80381830 P356 IOVS.06-0570 @default.
- Q80381830 P698 17525183 @default.
- Q80381830 P1433 Q6060707 @default.
- Q80381830 P1476 "Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis" @default.
- Q80381830 P2093 "Björn Bachmann" @default.
- Q80381830 P2093 "Claus Cursiefen" @default.
- Q80381830 P2093 "Felix Bock" @default.
- Q80381830 P2093 "Friedrich E Kruse" @default.
- Q80381830 P2093 "Grit Zahn" @default.
- Q80381830 P2093 "Jasmine Onderka" @default.
- Q80381830 P2093 "Matthias Paschke" @default.
- Q80381830 P2093 "Tina Dietrich" @default.
- Q80381830 P304 "2545-2552" @default.
- Q80381830 P31 Q13442814 @default.
- Q80381830 P356 "10.1167/IOVS.06-0570" @default.
- Q80381830 P433 "6" @default.
- Q80381830 P478 "48" @default.
- Q80381830 P577 "2007-06-01T00:00:00Z" @default.
- Q80381830 P698 "17525183" @default.
- Q80381830 P921 Q413299 @default.
- Q80381830 P921 Q539568 @default.